An overview of complications associated with deferoxamine therapy in thalassemia
Thalassemic syndromes are the most common genetic diseases in the world that are related to blood transfusion and iron overload in the body. In ß-thalassemia major multiple blood transfusions due to ineffective erythropoiesis lead to iron excess in the body. Iron chelating agent deferoxamine is used...
Guardado en:
Autores principales: | Bijan Keikhaei, Neda Farmani-Anooshe, Mohammad Bahadoram, Mohammad-Reza Mahmoudian-Sani, Kosar Alikhani, Ammar Helalinasab |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Society of Diabetic Nephropathy Prevention
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ae3243204daa484abb5acd62d0025edf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safety, clinical and laboratory characteristics of donors with thalassemia minor in living donor kidney transplant: a case series
por: Nhan Hieu Dinh, et al.
Publicado: (2021) -
Long-Term Effects of Iron Chelating Agents on Ocular Function in Patients with Thalassemia Major
por: Nuzzi R, et al.
Publicado: (2021) -
Occult Kidney Dysfunction in Children With Transfusion-Dependent Thalassemia
por: Nurwahida Mohd Zikre, et al.
Publicado: (2021) - Thalassemia reports
-
A brief overview of the development of robot-assisted radical prostatectomy
por: Oliver W. Hakenberg
Publicado: (2018)